{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T16:16:02Z","timestamp":1770826562818,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nursing Clinics of North America"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.cnur.2004.07.004","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T10:53:11Z","timestamp":1113821591000},"page":"845-861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Neurohormones and heart failure"],"prefix":"10.1016","volume":"39","author":[{"given":"Scott D.","family":"Mendzef","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer R.","family":"Slovinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cnur.2004.07.004_bib1","unstructured":"National Institutes of Health. NHLBI study finds improved heart failure survival. Available at: http:\/\/www.nhlbi.nih.gov\/news\/press\/02-10-30.htm. Accessed: February 27, 2003."},{"key":"10.1016\/j.cnur.2004.07.004_bib2","unstructured":"National Heart, Lung, Blood Institute Website. Lenfant C. Congestive heart failure in the United Statesz: a new epidemic [on-line serial]. Available at: http:\/\/www.nih.com. Accessed: November 1, 1999."},{"issue":"2","key":"10.1016\/j.cnur.2004.07.004_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00044067-199805000-00002","article-title":"Pathophysiology of heart failure update: the role of neurohormonal activation in the progression of heart failure","volume":"9","author":"Moser","year":"1998","journal-title":"AACN Clin Issues"},{"key":"10.1016\/j.cnur.2004.07.004_bib4","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/01.CIR.101.5.558","article-title":"B-Adrenergic receptor blockade in chronic heart failure","volume":"101","author":"Bristow","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cnur.2004.07.004_bib5","series-title":"Structure and function of the cardiovascular and lymphatic systems: pathophysiology: the biologic basis for disease in adults and children","first-page":"968","year":"1998"},{"key":"10.1016\/j.cnur.2004.07.004_bib6","series-title":"Mechanisms of hormonal regulation: pathophysiology: the biologic basis for disease in adult and children","author":"McCance","year":"1990"},{"issue":"Suppl","key":"10.1016\/j.cnur.2004.07.004_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(98)90016-2","article-title":"15 years of heart failure trials: what have we learned?","volume":"352","author":"Massie","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cnur.2004.07.004_bib8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1527-5299.2002.01157.x","article-title":"Beta-adrenergic blockade 2002: a pharmacologic odyssey in chronic heart failure","volume":"8","author":"Hermann","year":"2002","journal-title":"Congest Heart Fail"},{"issue":"1","key":"10.1016\/j.cnur.2004.07.004_bib9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3810\/pgm.1997.01.141","article-title":"Causes of congestive heart failure","volume":"101","author":"Bales","year":"1997","journal-title":"Postgrad Med"},{"issue":"Suppl","key":"10.1016\/j.cnur.2004.07.004_bib10","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1016\/S0002-8703(98)70252-2","article-title":"The pathophysiology of advanced heart failure","volume":"135","author":"Baig","year":"1998","journal-title":"Am Heart J"},{"key":"10.1016\/j.cnur.2004.07.004_bib11","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.RES.0000043825.01705.1B","article-title":"Inflammatory mediators and the failing heart: past, present and the foreseeable future","volume":"91","author":"Mann","year":"2002","journal-title":"Circ Res"},{"issue":"Suppl 1","key":"10.1016\/j.cnur.2004.07.004_bib12","first-page":"S119","article-title":"Successes and failures of current treatment of heart failure","volume":"352","author":"Cleland","year":"1998","journal-title":"Congest Heart Fail"},{"issue":"6","key":"10.1016\/j.cnur.2004.07.004_bib13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00003465-199611000-00004","article-title":"Retarding progression of heart failure: nursing actions","volume":"15","author":"Schwabauer","year":"1996","journal-title":"Dimens Crit Care Nurs"},{"issue":"Suppl","key":"10.1016\/j.cnur.2004.07.004_bib14","doi-asserted-by":"crossref","first-page":"S293","DOI":"10.1016\/S0002-8703(98)70257-1","article-title":"Optimizing therapy for complex of refractory heart failure: a management algorithm","volume":"135","author":"Stevenson","year":"1998","journal-title":"Am Heart J"},{"issue":"2A","key":"10.1016\/j.cnur.2004.07.004_bib15","first-page":"1A","volume":"83","year":"1999","journal-title":"Am J Cardiol"},{"issue":"Suppl 4","key":"10.1016\/j.cnur.2004.07.004_bib16","first-page":"S18","article-title":"Pharmacologic therapies for acutely decompensated heart failure","volume":"3","author":"Fonarow","year":"2002","journal-title":"Reviews in Cardiovascular Medicine"},{"key":"10.1016\/j.cnur.2004.07.004_bib17","series-title":"Contemporary diagnosis and management of heart failure","author":"Greenberg","year":"2002"},{"issue":"7","key":"10.1016\/j.cnur.2004.07.004_bib18","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1056\/NEJM199608153350707","article-title":"The management of chronic heart failure","volume":"335","author":"Cohn","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cnur.2004.07.004_bib19","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/01.CIR.100.9.999","article-title":"Mechanisms and models in heart failure a combined approach","volume":"100","author":"Mann","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.cnur.2004.07.004_bib20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1527-5299.2002.01158.x","article-title":"Congestive heart failure: potential role of arginine vasopressin antagonists in the therapy of heart failure","volume":"8","author":"Goldsmith","year":"2002","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.cnur.2004.07.004_bib21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cnur.2004.07.004_bib22","series-title":"The quiet heartbeat: a historical review of heart failure","author":"Astra Zeneca","year":"2000"},{"key":"10.1016\/j.cnur.2004.07.004_bib23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1071-9164(99)91340-4","article-title":"Practice guidelines: HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction \u2013 pharmacological approaches","volume":"5","author":"Heart Failure Society of America","year":"1999","journal-title":"J Card Fail"},{"issue":"2","key":"10.1016\/j.cnur.2004.07.004_bib24","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/00044067-199805000-00003","article-title":"Innovations in the pharmacologic management of heart failure","volume":"9","author":"Micheal","year":"1998","journal-title":"AACN Clin Issues"},{"issue":"10","key":"10.1016\/j.cnur.2004.07.004_bib25","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"327","author":"SOLVD Investigators","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cnur.2004.07.004_bib26","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"316","author":"The CONSENSUS Trial Study Group","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cnur.2004.07.004_bib27","unstructured":"Hunt SA, Baker DW, Chin MW, et al., ACC\/AHA guidelines for the evaluation and management of chronic heart failure in the adult: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure)."},{"issue":"1","key":"10.1016\/j.cnur.2004.07.004_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1751-7133.2003.tb00019.x","article-title":"The role of angiotensin ii receptor blockers in the treatment of heart failure patients","volume":"9","author":"Theal","year":"2003","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.cnur.2004.07.004_bib29","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1527-5299.2000.01156.x","article-title":"Angiotensin II receptor blockers in the treatment of heart failure","volume":"8","author":"Peterson","year":"2002","journal-title":"Congest Heart Fail"},{"issue":"9","key":"10.1016\/j.cnur.2004.07.004_bib30","first-page":"484","article-title":"How best to use digoxin in the treatment of CHF","volume":"14","author":"Haas","year":"1999","journal-title":"J Crit Iln"},{"issue":"8","key":"10.1016\/j.cnur.2004.07.004_bib31","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","author":"The Digitalis Investigation Group","year":"1997","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"10.1016\/j.cnur.2004.07.004_bib32","first-page":"S2","article-title":"Heart failure: the physiologic basis for current therapeutic concepts","volume":"19","author":"Albert","year":"1999","journal-title":"Crit Care Nurse"},{"key":"10.1016\/j.cnur.2004.07.004_bib33","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1527-5299.2002.01154.x","article-title":"\u201cBNP\u201d for heart failure: role of nesiritide in cardiovascular therapeutics","volume":"8","author":"Mills","year":"2002","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.cnur.2004.07.004_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1146\/annurev.med.52.1.15","article-title":"Pathophysiological role of cytokines in congestive heart failure","volume":"52","author":"Blum","year":"2001","journal-title":"Annu Rev Med"},{"issue":"Suppl 4","key":"10.1016\/j.cnur.2004.07.004_bib35","first-page":"S41","article-title":"Rapid optimization: strategies for optimal care of decompensated congestive heart-failure patients in the emergency department","volume":"3","author":"Peacock","year":"2002","journal-title":"Reviews in Cardiovascular Medicine"},{"key":"10.1016\/j.cnur.2004.07.004_bib36","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure (MERIT-HF)","volume":"353","author":"The MERIT-HF Study Group","year":"1999","journal-title":"Lancet"},{"issue":"Suppl I","key":"10.1016\/j.cnur.2004.07.004_bib37","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0140-6736(98)90017-4","article-title":"New targets for heart failure therapy: endothelin, inflammatory cytokines, and oxidative stress","volume":"352","author":"Givertz","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cnur.2004.07.004_bib38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00005082-199910000-00007","article-title":"Implementing a congestive heart failure disease management program to decrease length of stay and cost","volume":"14","author":"Knox","year":"1999","journal-title":"J Cardiovasc Nurs"},{"issue":"3","key":"10.1016\/j.cnur.2004.07.004_bib39","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000169004","article-title":"Endothelins as cardiovascular peptides","volume":"16","author":"Levin","year":"1996","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.cnur.2004.07.004_bib40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1527-5299.2002.01153.x","article-title":"Endothelin and endothelin receptor antagonists in heart failure","volume":"8","author":"Greenberg","year":"2002","journal-title":"Congest Heart Fail"},{"issue":"2","key":"10.1016\/j.cnur.2004.07.004_bib41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4037\/ajcc1998.7.2.131","article-title":"Nitric oxide and regulation of vascular tone: pharmacological and physiological considerations","volume":"7","author":"McHugh","year":"1998","journal-title":"Am J Crit Care"},{"key":"10.1016\/j.cnur.2004.07.004_bib42","series-title":"Control of cardiac output: cardiopulmonary critical care","author":"Dantzker","year":"1986"},{"key":"10.1016\/j.cnur.2004.07.004_bib43","series-title":"Cardiac failure. Pathophysiology: foundations of disease and clinical intervention","first-page":"368","year":"1998"},{"key":"10.1016\/j.cnur.2004.07.004_bib44","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1471-4892(02)00142-X","article-title":"B-Type natriuretic peptide for the treatment of congestive heart failure","volume":"2","author":"Schreiner","year":"2002","journal-title":"Curr Opin Pharmacol"},{"issue":"Suppl 4","key":"10.1016\/j.cnur.2004.07.004_bib45","first-page":"S10","article-title":"B-type natriuretic peptide measurements in diagnosing congest heart failure in the dyspneic emergency department patient","volume":"3","author":"Maiseel","year":"2002","journal-title":"Reviews in Cardiovascular Medicine"},{"issue":"5","key":"10.1016\/j.cnur.2004.07.004_bib46","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/paa.1999.111.5.406","article-title":"New therapeutic targets for the treatment of heart failure: the natriuretic peptides in heart failure: diagnostic and therapeutic potentials","volume":"111","author":"Chen","year":"1999","journal-title":"Proc Assoc Am Physicians"},{"issue":"Suppl 4","key":"10.1016\/j.cnur.2004.07.004_bib47","first-page":"S28","article-title":"Safety and efficacy of nesiritide for the treatment of decompensated heart failure","volume":"3","author":"Emerman","year":"2002","journal-title":"Reviews in Cardiovascular Medicine"},{"issue":"Suppl 4","key":"10.1016\/j.cnur.2004.07.004_bib48","first-page":"S3","article-title":"Acutely decompensated heart failure: opportunities to improve care and outcomes in the emergency department","volume":"3","author":"Aghababian","year":"2002","journal-title":"Reviews in Cardiovascular Medicine"},{"issue":"2","key":"10.1016\/j.cnur.2004.07.004_bib49","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/00002800-199503000-00004","article-title":"Advanced practice nurses can refine the management of heart failure","volume":"9","author":"Kegal","year":"1995","journal-title":"Clin Nurse Spec"}],"container-title":["Nursing Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002964650400074X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002964650400074X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T09:19:29Z","timestamp":1758446369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002964650400074X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S002964650400074X"],"URL":"https:\/\/doi.org\/10.1016\/j.cnur.2004.07.004","relation":{},"ISSN":["0029-6465"],"issn-type":[{"value":"0029-6465","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurohormones and heart failure","name":"articletitle","label":"Article Title"},{"value":"Nursing Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cnur.2004.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}